Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (847)	2/21/2005 2:37:45 PM
From: zeta1961	Read Replies (1) \| Respond to of 3722

<ambiguity or lacks specificity> Ambiguity..mois?..surely, you must be jesting<vbg>!..I just thought you could read my mind and know that I played PFE and chose to hold it through the w/e..trying to figure out my price point/time horizon..are the momo's going to run this up and then march it down?.. In early February, PFE had great news on their SU11248 molecule for gleevec resistant GIST(stopping a trial early because the experimental arm patients were doing so well) but it was eclipsed by the coxib issue and it's considered a nano-drop to their bottom line..I'm also not used to dealing with companies with market caps greater then a coupla' hundred million<g>..the SU molecule news would have propelled our others to da' moon<g> and me to Barcelona! Thanks Bernard..